Skip to main content
Premium Trial:

Request an Annual Quote

In Silico: Sep 1, 2001

Premium

GenomeWeb.COM Daily

 

“Obviously, you can fight this to the death, or you can agree to settle it.”

— Nanogen CFO Gerard Wills on the Nanogen/Motorola settlement over electricity-based DNA detection technology, in which Nanogen agreed to pay $5 million.

Find “Nanogen Reaches Settlement with Motorola in Patent Dispute” by searching: Nanogen

Proteins à Paris

Oxford Glycosciences and Hybrigenics have entered into a collaboration to study OGS’ protein drug targets. Hybrigenics will use modified yeast two-hybrid and similar cellular screening technologies to attempt to validate OGS’ proteins as involved in disease-related pathways.

Find “Hybrigenics to Study Interactions of OGS’ Protein Targets” by searching: OGS

 

So Long, Farewell

GenomicFX, an animal genomics company based in Austin, Texas, will close its doors in August, GenomeWeb learned. GenomicFX originally said it would create animal blood tests to help livestock breeders select animals as well as develop an identification tool to verify breed or origin.

Find “GenomicFX to Close Its Doors in August” by searching: GenomicFX

 

Speedy Smith-Waterman

Compaq and Edinburgh Biocomputing Systems said they had successfully achieved one billion comparisons per second running the Smith-Waterman algorithm on a single 1 GHz Alpha processor using EBS’ MPSRCH sequence analysis software. Compaq will begin shipping the 1 GHz Alphas in the fall.

Find “Compaq and EBS Break Billion Comparison-per-Second Barrier in 1 GHz Alpha Demo” by searching: EBS

 

Celera Sequel

While Celera Genomics and ABI focus on drug discovery and tools, Celera Diagnostics will begin building an industrial-scale genotyping facility in Alameda, Calif., to identify gene and protein markers for disease. It has not yet decided which specific disease to target, but it hopes to break into molecular, protein chemistry, and immunochemistry diagnostics.

Find “Celera Diagnostics Begins to Find Its Place Within Applera” by searching: Applera

 

BIOINFORM.COM WEEKLY

Bracing for a Boycott

Michael Eisen, ringleader of a looming 25,000-scientist boycott of the scientific journals, compared the current publishing process to a midwife who delivers a baby and then charges its parents to visit it.

Find “Public Library of Science Issues Ultimatum; Prepares for Journal Boycott, Self Publication” by searching: boycott

 

Back to School

BioInform publishes a comprehensive list of US universities offering bioinformatics BS, MS, and PhD programs with data on graduate job placement and administrators’ contact information.

Find “Bioinformatics Gains Foothold on US Campuses: 30 Universities Now Offer Degrees” by searching: campuses

 

BIOARRAYNEWS.COM WEEKLY

DIY Special

Need to order your own custom-designed oligonucleotide array at 3 a.m.? Now Affymetrix customers can do just that, with a new CustomExpress program and the company’s NetAffx website. Turnaround time for these made-to-order arrays, which cost $250 each in addition to a design fee, is currently four weeks. “We don’t think people expected they could do this with photolithography,” says Affymetrix president Sue Seigel.

Find: “New Affymetrix Offering Heats up Custom Array Market: Luminex to Launch Custom Bead Array,” by searching: Affymetrix

 

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.